drugset
drugset / Trial / NCT05624528

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

NCT05624528 ↗

Phase 2 Completed 49 enrolled University of Chicago
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.

Timeline

Start
2023-06-22
Primary completion
2026-06-01
Completion
2026-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolcapone Unknown 200 mg —

Indications

obsessive-compulsive disorder